Nilotinib - new step of success in CML therapy by E. G. Lomaia, A. Y. Zaritskey

Get full text

Nilotinib i dazatinibv 1-y linii terapii bol'nykhkhronicheskim mieloleykozomv khronicheskoy faze by N S Lazorko, E G Lomaia, E I Sbityakova, A Yu Zaritskiy

Get full text

Chronic myeloid leukemia — before and after imatinib (Third part) by E. G. Lomaia, M. Yu. Konopleva, E. G. Romanova, A. Yu. Zaritzkiy

Get full text

Efficacy and safety of tyrosine kinase inhibitors (dasatinib, nilotinib) in the treatment of chronic phase chronic myeloid leukemia by E. G. Lomaia, E. G. Romanova, E. I. Sbityakova, A. Yu. Zaritskiy

Get full text

Efficacy and safety of tyrosine kinase inhibitors (dasatinib, nilotinib) in the treatment of chronic phase chronic myeloid leukemia by E. G. Lomaia, E. G. Romanova, E. I. Sbityakova, A. Yu. Zaritskiy

Get full text

Chronic myeloid leukemia — before and after imatinib (First part) by E. G. Lomaia, D. V. Motorin, E. G. Romanova, A. Yu. Zaritzkiy

Get full text

Chronic myeloid leukemia — before and after imatinib (part II) by E. G. Lomaia, N. S. Lazorko, E. Salamatova, E. G. Romanova, A. Yu. Zaritzkiy

Get full text

Change of concentration of biochemical markers of dysfunction of endothelium at intake of inhibitors of tyrosinekinase of I and II generations at patients with a chronic myeloid le... by K. V. Naumova, I. L. Davydkin, E. G. Lomaia, T. Yu. Stepanova, T. P. Kuzmina, D. B. Zammoyeva

Get full text

Quality of life, symptom profile and clinical efficacy of second-line treatment with dasatinib in patients with imatinib-resistant or -intolerant chronic myeloid leukemia: results... by T. I. Ionova, T. P. Nikitina, E. G. Lomaia, G. B. Kuchma, E. R. Machyulaytene, E. I. Usacheva, T. V. Shnaider, A. Yu. Rodionova, K. A. Kurbatova

Get full text

CLINICAL AND LABORATORY FEATURES OF ESSENTIAL THROMBOCYTOSIS AND PRIMARY MYELOFIBROSIS DEPENDING ON JAK2 AND CALR1 MUTATION STATUS by E. G. lisina, N. T. Siordiya, P. A. Butylin, A. A. Silyutina, N. M. Matyukhina, O. M. Senderova, E. S. Fokina, V. A. Ovsepyan, E. G. Lomaia, A. Yu. Zaritskiy

Get full text

Cepeginterferon alfa-2b in the treatment of chronic myeloproliferative diseases by A L MELIKYAN, I N SUBORTSEVA, E A GILYAZITDINOVA, T I KOLOSHEJNOVA, E I PUSTOVAYA, E K EGOROVA, A M KOVRIGINA, A B SUDARIKOV, A O ABDULLAEV, E G LOMAIA, N T SIORDIYA, A Yu ZARITSKEY, V G SAVCHENKO

Get full text